Healthcare Industry Developments | BioTuesdays by Kilmer Lucas IR

Developments

Therapix reports positive topline results from Phase 2a obstructive sleep apnea trial

Therapix Biosciences (NASDAQ:TRPX) reported topline results from its Phase 2a clinical study of THX-110 for the treatment of obstructive sleep apnea (OSA). THX-110 is a combination of dronabinol, or synthetic THC, and...

November 13, 2019

Developments

Kadmon KD025 meets primary endpoint at interim analysis of pivotal GvHD trial

Kadmon Holdings’ (NYSE:KDMN) KD025 met its primary endpoint at an interim analysis of its registrational chronic graft-versus-host disease (cGVHD) trial. cGvHD is a deadly complication of hematopoietic stem cell...

November 12, 2019

Developments

X4 Pharma’s mavorixafor gets FDA breakthrough therapy designation for WHIM syndrome

The FDA granted X4 Pharmaceuticals’ (NASDAQ:XFOR) mavorixafor breakthrough therapy designation for WHIM syndrome. WHIM stands for warts; hypogammaglobulinemia, or low antibody levels; infections; and myelokathexis, or...

November 12, 2019

Developments

BriaCell to present clinical findings at San Antonio Breast Cancer Symposium

BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) will highlight its lead product candidate, Bria-IMT, in two poster sessions during the 2019 San Antonio Breast Cancer Symposium. The Dec. 12 poster will summarize the data...

November 12, 2019

Developments

Imagin Medical i/Blue imaging system on schedule for design verification

Imagin Medical (CSE:IME; OTCQB:IMEXF) is making progress towards design verification of its i/Blue Imaging System functional product. The company has purchased and received components from established suppliers to meet...

November 12, 2019

Developments

Cellular Biomedicine receives going private proposal

The board of Cellular Biomedicine Group (NASDAQ:CBMG) received a preliminary non-binding proposal from a consortium led by Tony Liu, CEO of Cellular, to acquire all the shares outstanding at a price of $19.50 each in a...

November 11, 2019

Developments

Liminal BioSciences presents new preclinical data at ASN Kidney Week

Liminal BioSciences (TSX:LMNL; OTCQX:PFSCF) and its collaborators presented new preclinical findings on a novel therapeutic approach to the treatment of inflammatory and fibrosis-related kidney diseases at the American...

November 11, 2019

Developments

Study finds therapeutic role for cannabis in PTSD depression

A new study in the peer-reviewed Journal of Psychopharmacology suggests that cannabis has an uplifting effect on people with post traumatic stress disorder (PTSD) and may a therapeutic role in addressing the condition...

November 8, 2019

Developments

Hepion to present on CRV431’s anti-fibrotic activity at the Liver Meeting 2019

Hepion Pharmaceuticals’ (NASDAQ:HEPA) CSO, Dr. Daren Ure, will present preclinical data on CRV431 at The Liver Meeting 2019. Dr. Ure’s presentation will address CRV431’s ability to decrease liver fibrosis in a carbon...

November 7, 2019

Developments

Vireo Health names Bruce Linton as executive chairman

Vireo Health International (CNSX:VREO; OTCQX:VREOF) appointed Bruce Linton to the role of executive chairman, where he will serve as a director, work closely with Vireo CEO and founder, Dr. Kyle Kingsley, and spearhead...

November 7, 2019

Therapix reports positive topline results from Phase 2a obstructive sleep apnea trial

Kadmon KD025 meets primary endpoint at interim analysis of pivotal GvHD trial

X4 Pharma’s mavorixafor gets FDA breakthrough therapy designation for WHIM syndrome

BriaCell to present clinical findings at San Antonio Breast Cancer Symposium

Imagin Medical i/Blue imaging system on schedule for design verification

Cellular Biomedicine receives going private proposal

Liminal BioSciences presents new preclinical data at ASN Kidney Week

Study finds therapeutic role for cannabis in PTSD depression

Hepion to present on CRV431’s anti-fibrotic activity at the Liver Meeting 2019

Vireo Health names Bruce Linton as executive chairman

Follow Us

Subscribe

General

More

Subscribe